Gianluca Ingrosso
Overview
Explore the profile of Gianluca Ingrosso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
739
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, et al.
Prostate Cancer Prostatic Dis
. 2025 Feb;
PMID: 39972049
ARTO trial was a phase II randomized trial suggesting the benefit of a concomitant treatment strategy including Abiraterone acetate plus predisone (AAP) and stereotactic body radiotherapy (SBRT) in oligometastatic castrate...
2.
Abancourt L, Ali M, Quivrin M, Wallet J, Schick U, Ingrosso G, et al.
Eur Urol Oncol
. 2025 Feb;
PMID: 39920013
Background And Objective: For inoperable patients, stereotactic body radiation therapy (SBRT) is a noninvasive treatment approach for primary renal cell carcinoma (RCC). We aimed to evaluate local control (LC) of...
3.
4.
Lancia A, Ingrosso G, Detti B, Festa E, Bonzano E, Linguanti F, et al.
Front Oncol
. 2024 Sep;
14:1455428.
PMID: 39314633
The therapeutic landscape of metastatic prostate cancer has undergone a profound revolution in recent years. In addition to the introduction of novel molecules in the clinics, the field has witnessed...
5.
Ingrosso G, Lancia A, Festa E, Pisani A, Bellavita R, Aristei C, et al.
Expert Rev Anticancer Ther
. 2024 Apr;
24(7):477-479.
PMID: 38682638
No abstract available.
6.
Ingrosso G, Ponti E, Francolini G, Caini S, Fondelli S, Santini R, et al.
Radiol Med
. 2024 Feb;
129(4):643-652.
PMID: 38369638
Background: Moderate hypofractionated radiotherapy is a treatment option for the cure of localized prostate cancer (PCa) patients based on the results of randomized prospective trials, but there is a clinical...
7.
Francolini G, Allegra A, Detti B, Di Cataldo V, Caini S, Bruni A, et al.
J Clin Oncol
. 2023 Sep;
41(36):5561-5568.
PMID: 37733977
Purpose: ARTO (ClinicalTrials.gov identifier: NCT03449719) is a multicenter, phase II randomized clinical trial testing the benefit of adding stereotactic body radiation therapy (SBRT) to abiraterone acetate and prednisone (AAP) in...
8.
Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G, et al.
Strahlenther Onkol
. 2023 Jun;
199(12):1173-1190.
PMID: 37347290
Objective: Tumor-associated macrophages (TAMs) are the most represented cells of the immune system in the tumor microenvironment (TME). Besides its effects on cancer cells, radiation therapy (RT) can alter TME...
9.
Arcangeli S, Lancia A, Ingrosso G, Triggiani L, Wilkins A
Front Oncol
. 2023 May;
13:1196769.
PMID: 37124515
No abstract available.
10.
Perrucci E, Marcantonini M, Arena E, Fulcheri C, Reggioli V, Dipilato A, et al.
Rep Pract Oncol Radiother
. 2023 May;
28(1):1-8.
PMID: 37122911
Background: In patients with expander-based reconstruction a few dosimetric analyses detected radiation therapy dose perturbation due to the internal port of an expander, potentially leading to toxicity or loss of...